While the C-peptide test is a powerful tool, it does have limitations. For instance, it may not be suitable for individuals with severe kidney disease, as C-peptide is cleared through the kidneys. Additionally, it might not accurately reflect insulin levels in patients who are taking exogenous insulin. These factors must be considered in epidemiological studies to ensure the validity and reliability of the data obtained.
